Allelic diversity and phylogeny of homB, a novel co-virulence marker of Helicobacter pylori.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 2795765)

Published in BMC Microbiol on December 02, 2009

Authors

Mónica Oleastro1, Rita Cordeiro, Armelle Ménard, Yoshio Yamaoka, Dulciene Queiroz, Francis Mégraud, Lurdes Monteiro

Author Affiliations

1: Departamento de Doenças Infecciosas, Instituto Nacional Saúde Dr Ricardo Jorge, Av. Padre Cruz, 1649-016 Lisboa, Portugal. monica.oleastro@insa.min-saude.pt

Articles citing this

Evolution in an oncogenic bacterial species with extreme genome plasticity: Helicobacter pylori East Asian genomes. BMC Microbiol (2011) 1.58

Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One (2010) 1.48

Helicobacter pylori bab Paralog Distribution and Association with cagA, vacA, and homA/B Genotypes in American and South Korean Clinical Isolates. PLoS One (2015) 1.41

Inducible nitric oxide synthetase genotype and Helicobacter pylori infection affect gastric cancer risk. World J Gastroenterol (2012) 1.22

Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol (2010) 1.03

Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J Gastroenterol (2013) 1.02

Helicobacter pylori homB, but not cagA, is associated with gastric cancer in Iran. J Clin Microbiol (2011) 0.99

The Role of Helicobacter pylori Outer Membrane Proteins in Adherence and Pathogenesis. Biology (Basel) (2013) 0.89

Allelic diversity among Helicobacter pylori outer membrane protein genes homB and homA generated by recombination. J Bacteriol (2010) 0.83

The geographic origin of Helicobacter pylori influences the association of the homB gene with gastric cancer. J Clin Microbiol (2012) 0.80

In silico evolutionary analysis of Helicobacter pylori outer membrane phospholipase A (OMPLA). BMC Microbiol (2012) 0.77

Reduced genome size of Helicobacter pylori originating from East Asia. World J Gastroenterol (2014) 0.76

Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases. World J Gastroenterol (2016) 0.75

Articles cited by this

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75

MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform (2004) 72.40

EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet (2000) 69.26

Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06

The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature (1997) 34.00

Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature (1999) 19.34

Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science (1998) 6.99

Phase and antigenic variation in bacteria. Clin Microbiol Rev (2004) 5.02

Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut (1997) 4.70

Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science (2002) 4.38

Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology (1998) 4.11

A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66

Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology (1999) 3.37

Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology (2002) 3.27

Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol (2005) 3.25

Emergence of recombinant strains of Helicobacter pylori during human infection. Mol Microbiol (1999) 3.25

Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun (2000) 3.13

The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. Proc Natl Acad Sci U S A (2006) 3.07

Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut (1998) 2.84

Ecology of Helicobacter pylori in the human stomach. J Clin Invest (1997) 2.77

Modification of Helicobacter pylori outer membrane protein expression during experimental infection of rhesus macaques. Proc Natl Acad Sci U S A (2004) 2.35

Allelic Variation within Helicobacter pylori babA and babB. Infect Immun (2001) 2.02

Conservation, localization and expression of HopZ, a protein involved in adhesion of Helicobacter pylori. Nucleic Acids Res (1999) 1.97

Metastability of Helicobacter pylori bab adhesin genes and dynamics in Lewis b antigen binding. Proc Natl Acad Sci U S A (2004) 1.71

Concerted evolution between duplicated genetic elements in Helicobacter pylori. J Mol Biol (2002) 1.68

Gene conversion and concerted evolution in bacterial genomes. FEMS Microbiol Rev (2005) 1.57

The diversity within an expanded and redefined repertoire of phase-variable genes in Helicobacter pylori. Microbiology (2004) 1.54

Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol (2002) 1.53

Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect Immun (2004) 1.45

Two different families of hopQ alleles in Helicobacter pylori. J Clin Microbiol (2002) 1.25

Transcriptional phase variation of a type III restriction-modification system in Helicobacter pylori. J Bacteriol (2002) 1.23

Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis (2008) 1.14

Adaptation by phase variation in pathogenic bacteria. Adv Appl Microbiol (2003) 1.10

Disease association with two Helicobacter pylori duplicate outer membrane protein genes, homB and homA. Gut Pathog (2009) 1.07

Identification of markers for Helicobacter pylori strains isolated from children with peptic ulcer disease by suppressive subtractive hybridization. Infect Immun (2006) 1.06

Analysis of hopQ alleles in East Asian and Western strains of Helicobacter pylori. FEMS Microbiol Lett (2005) 1.04

Genetic diversity of the HpyC1I restriction modification system in Helicobacter pylori. Res Microbiol (2007) 0.79

Articles by these authors

Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet (2011) 5.48

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68

The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14

Campylobacter. Vet Res (2005) 2.74

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet (2005) 2.61

Sequential therapy for Helicobacter pylori eradication: a critical review. J Clin Gastroenterol (2010) 2.57

Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl (2005) 2.43

A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41

Prevalence of Helicobacter pylori infection in long-term hemodialysis patients. Kidney Int (2008) 2.39

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32

Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology (2011) 2.13

Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03

Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter (2011) 2.00

Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91

Contribution of bone marrow cells to liver regeneration after partial hepatectomy in mice. J Hepatol (2002) 1.91

Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg (2007) 1.82

Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach. Clin Cancer Res (2006) 1.79

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol (2005) 1.79

Report of the 15th follow-up survey of primary liver cancer. Hepatol Res (2004) 1.78

Impact of chronic Helicobacter pylori infection on Alzheimer's disease: preliminary results. Neurobiol Aging (2011) 1.63

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res (2004) 1.60

Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol (2003) 1.60

Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery (2005) 1.54

Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol (2005) 1.53

c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest (2012) 1.53

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs (2008) 1.48

Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47

Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res (2002) 1.46

Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44

Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg (2005) 1.44

The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J Neurol (2011) 1.44

Prognostic accuracy of five simple scales in childhood bacterial meningitis. Scand J Infect Dis (2012) 1.44

Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol (2011) 1.44

Perioperative changes in carbonylhemoglobin and methemoglobin during abdominal surgery: alteration in endogenous generation of carbon monoxide. J Gastroenterol Hepatol (2002) 1.43

New methods for detection of campylobacters in stool samples in comparison to culture. J Clin Microbiol (2011) 1.43

Analysis of Helicobacter pylori genotypes and correlation with clinical outcome in Turkey. J Clin Microbiol (2004) 1.42

Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am J Gastroenterol (2005) 1.40

Diagnosis and epidemiology of Helicobacter pylori infection. Helicobacter (2013) 1.39

Aminopeptidase N is involved in cell motility and angiogenesis: its clinical significance in human colon cancer. Gastroenterology (2002) 1.39

Association between Helicobacter pylori virulence factors and gastroduodenal diseases in Okinawa, Japan. J Clin Microbiol (2011) 1.37

Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol Biol Cell (2005) 1.37

Arcobacter butzleri: underestimated enteropathogen. Emerg Infect Dis (2006) 1.37

Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg (2002) 1.35

Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter (2004) 1.35

Delivery of matrix metalloproteinase-1 attenuates established liver fibrosis in the rat. Gastroenterology (2003) 1.34

Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island. Am J Gastroenterol (2002) 1.34

A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. PLoS One (2009) 1.34

Diagnosis of Helicobacter pylori Infection. Helicobacter (2005) 1.33

Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter (2003) 1.31

Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma. Infect Immun (2004) 1.30

Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res (2003) 1.28

Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter (2012) 1.27

Correlation between Helicobacter pylori OipA protein expression and oipA gene switch status. J Clin Microbiol (2004) 1.27

Ancestral European roots of Helicobacter pylori in India. BMC Genomics (2007) 1.26

Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect (2006) 1.25

PCR-restriction fragment length polymorphism analysis for detection of point mutations associated with macrolide resistance in Campylobacter spp. Antimicrob Agents Chemother (2003) 1.25

Report of the 16th follow-up survey of primary liver cancer. Hepatol Res (2005) 1.25

Helicobacter pylori infection and gastric cancer. Eur J Cancer (2006) 1.24

Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol (2010) 1.24

Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol (2004) 1.23

New pathogenicity marker found in the plasticity region of the Helicobacter pylori genome. J Clin Microbiol (2003) 1.21

Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol (2003) 1.21

Pathogen evolution in vivo: genome dynamics of two isolates obtained 9 years apart from a duodenal ulcer patient infected with a single Helicobacter pylori strain. J Clin Microbiol (2005) 1.20

vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. Jpn J Infect Dis (2008) 1.20

PCR-restriction fragment length polymorphism can also detect point mutation A2142C in the 23S rRNA gene, associated with Helicobacter pylori resistance to clarithromycin. Antimicrob Agents Chemother (2002) 1.19

Helicobacter pylori activate epidermal growth factor receptor- and phosphatidylinositol 3-OH kinase-dependent Akt and glycogen synthase kinase 3beta phosphorylation. Cell Microbiol (2008) 1.19

vacA i-region subtyping. Gastroenterology (2008) 1.18

Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway. J Biol Chem (2008) 1.17

Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg (2002) 1.17

IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Helicobacter (2008) 1.17

Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter (2002) 1.16

From array-based hybridization of Helicobacter pylori isolates to the complete genome sequence of an isolate associated with MALT lymphoma. BMC Genomics (2010) 1.16

Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol (2013) 1.16

The significance of virulence factors in Helicobacter pylori. J Dig Dis (2013) 1.16

Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol (2002) 1.16

Is the molecular basis of metronidazole resistance in microaerophilic organisms understood? Trends Microbiol (2002) 1.15

Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease. J Infect Dis (2008) 1.14

Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13

Comparison of genotyping Helicobacter pylori directly from biopsy specimens and genotyping from bacterial cultures. J Clin Microbiol (2003) 1.13

Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol (2002) 1.13

Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci (2004) 1.13

Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori. Infect Immun (2005) 1.12

Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am (2003) 1.11

Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One (2011) 1.11